Neuroprotective Effects of Antidepressants via Upregulation of Neurotrophic Factors in the MPTP Model of Parkinson’s Disease

Prospects of Neurotrophic Factors for Parkinson's Disease: Comparison of Protein and Gene Therapy

(2015) Andrii Domanskyi et al.   HUMAN GENE THERAPY

Transport of Glial Cell Line-Derived Neurotrophic Factor into Liposomes across the Blood-Brain Barrier: In Vitro and in Vivo Studies

(2014) Shaoling Wu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Chronic Amitriptyline Treatment Attenuates Nigrostriatal Degeneration and Significantly Alters Trophic Support in a Rat Model of Parkinsonism

(2014) Katrina L Paumier et al.   NEUROPSYCHOPHARMACOLOGY

GDNF, NGF and BDNF as therapeutic options for neurodegeneration

(2013) Shelley J. Allen et al.   PHARMACOLOGY & THERAPEUTICS

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

(2013) Sheila M. Fleming et al.   Jove-Journal of Visualized Experiments

Therapies in Parkinsonʼs disease

(2012) Joseph Jankovic et al.   CURRENT OPINION IN NEUROLOGY

Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy

(2012) Kiren Ubhi et al.   EXPERIMENTAL NEUROLOGY

Tricyclic antidepressants delay the need for dopaminergic therapy in early Parkinson's disease

(2012) Katrina L. Paumier et al.   MOVEMENT DISORDERS

Disease Modification in Parkinsonʼs Disease

(2011) Claire Henchcliffe et al.   DRUGS & AGING

Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation

(2011) Young C. Chung et al.   NEUROPHARMACOLOGY

Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes

(2011) Igor Allaman et al.   PSYCHOPHARMACOLOGY

Antidepressant Treatment Restores Brain-Derived Neurotrophic Factor Serum Levels and Ameliorates Motor Function in Parkinson Disease Patients

(2010) Valerio Ricci et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Diagnosis and Treatment of Depression Comorbid with Neurologic Disorders

(2009) Murray A. Raskind   AMERICAN JOURNAL OF MEDICINE

Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

(2009) Alan H Nagahara et al.   NATURE MEDICINE

Effective GDNF brain delivery using microspheres—A promising strategy for Parkinson's disease

(2008) E. Garbayo et al.   JOURNAL OF CONTROLLED RELEASE

Quality of life in Parkinson's disease: The relative importance of the symptoms

(2008) Shibley Rahman et al.   MOVEMENT DISORDERS

MPTP-induced deficits in striatal synaptic plasticity are prevented by glial cell line-derived neurotrophic factor expressed via an adeno-associated viral vector

(2007) Yuan-Hao Chen et al.   FASEB JOURNAL

Antidepressant drug treatments induce glial cell line-derived neurotrophic factor (GDNF) synthesis and release in rat C6 glioblastoma cells

(2003) Kazue Hisaoka et al.   JOURNAL OF NEUROCHEMISTRY